ONUREG (azacitidine) is an oral prescription medicine used to treat adults with acute myeloid leukemia (AML) who are in first complete remission (CR) (with or without recovery of your blood cell counts) after intensive induction chemotherapy and are not able to complete intensive curative therapy.
It is not known if ONUREG is safe and effective in children under 18 years of age.
About AML Remission
Treating your AML after remission
People with acute myeloid leukemia (AML) can have different treatment journeys
After remission, each person's journey is different.* Talk to your healthcare team about choosing a treatment path that is right for you.
* Some people are watched closely after remission, but not treated until their AML comes back. Doctors call this ‘active surveillance’ or ‘watch and wait’.